By leveraging AI and machine learning, researchers can analyze complex data sets, identify novel biomarkers, and provide more effective and tailored treatment options for cancer patients.
With the information contained in a simple 30-second voice sample, providers can help patients get ahead of future health issues and prescribe or adjust treatment plans as needed.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Blending computational biology and AI-based methods, the goal is to identify new targets, pair these with effective chemistry, and define biomarkers to optimally position novel therapies.
Before the pandemic started, the U.S. Department of Defense and Philips designed a system to detect potential infections before symptoms appear. Now, they’re turning it on the Covid-19 pandemic.
The FDA approved Keytruda as a single agent for patients with first-line metastatic or unresectable colorectal cancer that carries the biomarker MSI-H or dMMR. The drug was the first to win a biomarker-based, tumor-agnostic label, in 2017.
Integrating the NCCN's Biomarker Compendium data into Syapse's products is designed to aid finding targeted drugs and clinical trials while improving physician workflow.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Lower costs for capital and sequencing, a friendlier regulatory and reimbursement environment and growth in precision medicine are among driving factors.
Forecast of significant growth in market comes after Roche acquired remaining stake in Foundation Medicine last month.
If approved, LOXO-101 (larotrectinib) would be the second drug to win a biomarker-based label, after Merck's Keytruda.
It is the latest in a series of developments for diagnostics business Owlstone Medical, which recently brought its breath biopsy kits to market.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The number of digital health apps has doubled in recent years to 318,000. Increased clinical validation has led to wider adoption of apps and sensors by pharma companies and healthcare systems to remotely monitor patients and quantify medication adherence.
There's still a gap between potential and validation when it comes to digital biomarkers.
The biomarker market is booming, and it's projected to keep soaring significantly.
For diseases like Parkinson’s and Alzheimer’s, it seems like symptoms are a function of what’s going on deep down inside of whoever is afflicted – a reflection of something happening at the core. But what if detection could be right in front of our faces, just on the surface of a patient’s skin? Dr. Ildefonso […]
More than 25 million people in the U.S. have asthma, but diagnosing it and figuring out what triggers it can be challenging, especially in young children. An “electronic nose” device being tested by a team at Academic Medical Centre in Amsterdam aims to make the one-size-fits-all approach to asthma treatment a thing of the past. […]